The long-term survival of patients with III-IVb stage nasopharyngeal carcinoma treated with IMRT with or without Nimotuzumab: a propensity score-matched analysis

The long-term survival of patients with III-IVb stage nasopharyngeal carcinoma treated with IMRT with or without Nimotuzumab: a propensity score-matched analysis

Abstract Background To assess the efficacy of Nimotuzumab in combination with first-line chemoradiotherapy treatment in Chinese patients with primary III-IVb stage nasopharyngeal carcinoma. Methods Patients with primary locoregionally advanced nasopharyngeal carcinoma who were treated with intensity...

Full description

Bibliographic Details
Main Authors: Wang Zhi-Qiang, Mei Qi, Li Ji-Bin, You Rui, Liu You-Ping, Sun Rui, Hu Guang-Yuan, Chen Ming-Yuan, Hua Yi-Jun
Format: Article
Language:English
Published: BMC 2019-11-01
Series:BMC Cancer
Subjects:
Nasopharyngeal carcinoma
IMRT
Chemotherapy
Nimotuzumab
Prognosis
Online Access:http://link.springer.com/article/10.1186/s12885-019-6156-5

Internet

http://link.springer.com/article/10.1186/s12885-019-6156-5

Similar Items